Manchester Capital Management LLC

Source: SEC Form 13F · as of Mar 2026

Manchester Capital Management LLC holds 72 biotech & pharma companies tracked by BioSniper, totaling $30.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

72

Total value held

$30.3M

CompanySharesValue
JNJJOHNSON & JOHNSON21,891$5.4M
MRKMerck & Co., Inc.36,254$4.4M
ABBVAbbVie Inc.18,973$4.1M
LLYELI LILLY & Co3,864$3.6M
GILDGILEAD SCIENCES, INC.13,270$1.8M
ABTABBOTT LABORATORIES17,449$1.8M
UNHUnitedHealth Group Incorporated Common Stock (DE)5,282$1.4M
AMGNAMGEN INC4,034$1.4M
PFEPFIZER INC32,827$922K
CORCencora Inc.2,747$863K
BMYBRISTOL MYERS SQUIBB CO13,214$801K
PMPhilip Morris International Inc2,612$432K
NVONovo Nordisk A/S11,611$427K
MCKMcKesson Corporation424$367K
NVSNovartis AG1,910$292K
WSTWest Pharmaceutical Services Inc.1,131$283K
AZNASTRAZENECA PLC1,415$279K
ELVElevance Health Inc.788$231K
VRTXVERTEX PHARMACEUTICALS INC / MA396$177K
ZTSZoetis Inc.1,474$174K
INSMINSMED Inc1,017$166K
BIIBBIOGEN INC.901$165K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)4,649$86K
ZBHZimmer Biomet Holdings Inc.868$78K
SNYSanofi1,607$77K
IDXXIDEXX LABORATORIES INC /DE115$65K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,096$60K
VTRSViatris Inc4,471$60K
GMOptec International, Inc.725$54K
CAHCardinal Health Inc.209$44K
QGENQIAGEN N.V.894$36K
REGNREGENERON PHARMACEUTICALS, INC.46$36K
ALNYALNYLAM PHARMACEUTICALS, INC.86$28K
RPRXRoyalty Pharma plc587$28K
ABVXAbivax SA200$22K
DGXQuest Diagnostics Incorporated113$22K
IQVIQVIA Holdings Inc.118$20K
CRSPCRISPR Therapeutics AG400$19K
MRNAModerna, Inc.372$19K
GEHCGE HealthCare Technologies Inc.202$14K
GMABGenmab A/S336$9K
TECHBIO-TECHNE Corp161$8K
DVADaVita Inc.50$8K
OGNOrganon & Co.1,012$6K
JAZZJazz Pharmaceuticals plc32$6K
ADILADIAL PHARMACEUTICALS, INC.1,923$3K
INCYIncyte Corp.31$3K
ELANElanco Animal Health Inc119$3K
KYMRKymera Therapeutics, Inc.31$3K
BMRNBIOMARIN PHARMACEUTICAL INC45$3K
UTHRUNITED THERAPEUTICS Corp4$2K
NEOGNEOGEN CORP246$2K
LGNDLigand Pharmaceuticals Incorporated9$2K
ICUIICU Medical Inc.12$2K
CGONCG Oncology, Inc.22$1K
NBIXNEUROCRINE BIOSCIENCES INC11$1K
APLSApellis Pharmaceuticals, Inc.28$1K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.6$1K
MOHMolina Healthcare Inc7$934
TEVATeva Pharmaceutical Industries Limited28$844
GRFSGrifols S.A.90$722
ALKSAlkermes plc.20$708
DNLIDenali Therapeutics Inc.36$692
CORTCORCEPT THERAPEUTICS INC17$686
SHCSotera Health Company43$617
INSPInspire Medical Systems Inc.11$568
PGNYProgyny Inc.33$561
AGIOAGIOS PHARMACEUTICALS, INC.16$542
MEDPMedpace Holdings Inc.1$481
IONSIONIS PHARMACEUTICALS INC5$376
RGENREPLIGEN CORP1$118
SRPTSarepta Therapeutics, Inc.2$44

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Manchester Capital Management LLC — Biotech 13F Holdings & Portfolio | BioSniper